Search details
1.
Discovery of potent and selective Spleen Tyrosine Kinase inhibitors for the topical treatment of inflammatory skin disease.
Bioorg Med Chem Lett
; 28(21): 3458-3462, 2018 11 15.
Article
in English
| MEDLINE | ID: mdl-30249354
2.
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.
Nat Chem Biol
; 11(3): 189-91, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25622091
3.
Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors.
Bioorg Med Chem Lett
; 26(19): 4606-4612, 2016 10 01.
Article
in English
| MEDLINE | ID: mdl-27578246
4.
Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor.
Bioorg Med Chem Lett
; 21(20): 6188-94, 2011 Oct 15.
Article
in English
| MEDLINE | ID: mdl-21903390
Results
1 -
4
de 4
1
Next >
>>